David Berry
InvestorBoard director at Seres Therapeutics · Board director at Pronutria Biosciences
Cambridge, Massachusetts, United States
Writes $500K – $15M checks
Find your path to David
771 people in our graph can introduce you to David.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Anika Gupta to introduce you to David
You →Anika · together at Flagship Pioneering (2017–2018) →David
Ask Jamie Chen to introduce you to David
You →Jamie · 11 people · together at Flagship Pioneering →David
Sign up to find every way you can get introduced to David
- Your email: the people you already email who know David
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with David
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Physician-scientist turned investor who cofounded 20+ companies including Moderna, Valo Health and Seres, often serving as inventor and hands-on CEO and applying AI/computation to reshape drug discovery.
Invests in
AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech
Board director at Seres Therapeutics
Intro paths
In turn, David can intro founders to Seres Therapeutics's investors below.
Board director at Pronutria Biosciences
Intro paths
In turn, David can intro founders to Pronutria Biosciences's investors below.
Experience
- AverinManaging Partnercurrent2025 — present
- United Nations Sustainable Development Solutions NetworkLeadership Council Member (2012-2018) Emeritus (2018-present)current2012 — presentNew York City Metropolitan Area
- Hackley SchoolTrustee (Board Member 2010-2019, Advisory Member 2019-present)current2010 — presentTarrytown, NY
- Valo HealthFounder and CEO2018 — 2024
- Flagship PioneeringGeneral Partner2005 — 2024Cambridge, MA
- Boston Philharmonic OrchestraBoard Member2010 — 2014
- Massachusetts Institute of TechnologyCorporation Member2006 — 2011
Skills & more
+12 more
Process SimulationDue DiligenceCorporate DevelopmentCommercializationMergersRenewable EnergyPharmaceutical IndustryTechnology TransferAngel InvestingR&DPrivate EquityStrategic PartnershipsFrom David's professional profile.
Deals · 1
Pronutria BiosciencesBoard seat
via Flagship Pioneering · filed Feb 2016
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
AvedroAxcellaJoule Unlimited TechnologiesKSQ TherapeuticsLS9Seres TherapeuticsSesen Bio
Sources: SEC Form D filings · curated public sources.
Network2
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Who is David Berry?
- Physician-scientist turned investor who cofounded 20+ companies including Moderna, Valo Health and Seres, often serving as inventor and hands-on CEO and applying AI/computation to reshape drug discovery.
- Where does David Berry work?
- David Berry is Board director at Seres Therapeutics and Board director at Pronutria Biosciences.
- What does David Berry invest in?
- David Berry invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, FoodTech, Healthtech.
- What check size does David Berry write?
- David Berry typically writes checks of $500K – $15M.
- What boards does David Berry sit on?
- David Berry holds tracked board seats at Pronutria Biosciences, Seres Therapeutics.
- What companies has David Berry invested in?
- Investments tracked here include Avedro, Axcella, Joule Unlimited Technologies, KSQ Therapeutics, LS9, Seres Therapeutics, Sesen Bio.
- Where did David Berry go to school?
- David Berry studied at Massachusetts Institute of Technology (BS, PhD); Harvard Medical School (MD); Massachusetts Institute of Technology (PhD, Biological Engineering).
Same school
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Also attended Harvard Medical School320
+ 314 more
Shared employers
Also worked at Valo Health7
+ 1 more
Also worked at Flagship Pioneering106
+ 100 more
Also worked at Massachusetts Institute of Technology885
+ 879 more


































